<SEC-DOCUMENT>0001140361-25-046189-index.html : 20251219
<SEC-HEADER>0001140361-25-046189.hdr.sgml : 20251219
<ACCEPTANCE-DATETIME>20251219160542
ACCESSION NUMBER:		0001140361-25-046189
CONFORMED SUBMISSION TYPE:	15-12G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20251219
DATE AS OF CHANGE:		20251219
EFFECTIVENESS DATE:		20251219

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Akero Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001744659
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		15-12G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38944
		FILM NUMBER:		251587523

	BUSINESS ADDRESS:	
		STREET 1:		601 GATEWAY BOULEVARD, SUITE 350
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		650-487-6488

	MAIL ADDRESS:	
		STREET 1:		601 GATEWAY BOULEVARD, SUITE 350
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>15-12G
<SEQUENCE>1
<FILENAME>ef20061504_15-12g.htm
<DESCRIPTION>15-12G
<TEXT>
Document 1 - file: ef20061504_15-12g.htm

</DOCUMENT>
</SEC-DOCUMENT>